阴沟肠杆菌血流感染临床和微生物学结果不佳的相关因素:一项多中心回顾性队列研究。

IF 8.2 1区 医学 Q1 IMMUNOLOGY
Adriana Jimenez, Rossana Rosa, Samantha Ayoub, Rachel Guran, Sebastian Arenas, Nickolas Valencia, Janna C Stabile, Adrian T Estepa, Dipen J Parekh, Tanira Ferreira, Hayley B Gershengorn, Kavitha K Prabaker, Paula A Eckardt, Matthew Zahn, Lilian M Abbo, Bhavarth S Shukla
{"title":"阴沟肠杆菌血流感染临床和微生物学结果不佳的相关因素:一项多中心回顾性队列研究。","authors":"Adriana Jimenez, Rossana Rosa, Samantha Ayoub, Rachel Guran, Sebastian Arenas, Nickolas Valencia, Janna C Stabile, Adrian T Estepa, Dipen J Parekh, Tanira Ferreira, Hayley B Gershengorn, Kavitha K Prabaker, Paula A Eckardt, Matthew Zahn, Lilian M Abbo, Bhavarth S Shukla","doi":"10.1093/cid/ciae411","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>C. auris has become a growing concern worldwide due to increases in incidence of colonization and reports of invasive infections. There are limited data on clinical factors associated with poor outcomes in patients with C. auris bloodstream infection (BSI).</p><p><strong>Methods: </strong>We assembled a multicenter retrospective cohort of patients with C. auris BSI from two geographics areas in US healthcare settings. We collected data on demographic, clinical, and microbiologic characteristics to describe the cohort and constructed multivariate logistic regression models to understand risk factors for two clinical outcomes, all-cause mortality during facility admission, and blood culture clearance.</p><p><strong>Results: </strong>Our cohort consisted of 187 patients with C. auris BSI (56.1% male, 55.6% age >65 years); 54.6% died by facility discharge and 66.9% (of 142 with available data) experienced blood culture clearance. Pitt bacteremia score at infection onset was associated with mortality (odds-ratio [95% confidence interval]: 1.19 [1.01,1.40] per 1-point increase). Hemodialysis was associated with a reduced odds of microbiologic clearance (0.15 [0.05,0.43]) and with mortality (3.08 [1.27,7.50]).</p><p><strong>Conclusions: </strong>The Pitt bacteremia score at the onset of C. auris BSI may be a useful tool in identifying patients at risk for mortality. Targeted infection prevention practices in patients receiving hemodialysis may be useful to limit poor outcomes.</p>","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":8.2000,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Factors Associated with Poor Clinical and Microbiologic Outcomes in C. auris Bloodstream Infection: A Multicenter Retrospective Cohort Study.\",\"authors\":\"Adriana Jimenez, Rossana Rosa, Samantha Ayoub, Rachel Guran, Sebastian Arenas, Nickolas Valencia, Janna C Stabile, Adrian T Estepa, Dipen J Parekh, Tanira Ferreira, Hayley B Gershengorn, Kavitha K Prabaker, Paula A Eckardt, Matthew Zahn, Lilian M Abbo, Bhavarth S Shukla\",\"doi\":\"10.1093/cid/ciae411\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>C. auris has become a growing concern worldwide due to increases in incidence of colonization and reports of invasive infections. There are limited data on clinical factors associated with poor outcomes in patients with C. auris bloodstream infection (BSI).</p><p><strong>Methods: </strong>We assembled a multicenter retrospective cohort of patients with C. auris BSI from two geographics areas in US healthcare settings. We collected data on demographic, clinical, and microbiologic characteristics to describe the cohort and constructed multivariate logistic regression models to understand risk factors for two clinical outcomes, all-cause mortality during facility admission, and blood culture clearance.</p><p><strong>Results: </strong>Our cohort consisted of 187 patients with C. auris BSI (56.1% male, 55.6% age >65 years); 54.6% died by facility discharge and 66.9% (of 142 with available data) experienced blood culture clearance. Pitt bacteremia score at infection onset was associated with mortality (odds-ratio [95% confidence interval]: 1.19 [1.01,1.40] per 1-point increase). Hemodialysis was associated with a reduced odds of microbiologic clearance (0.15 [0.05,0.43]) and with mortality (3.08 [1.27,7.50]).</p><p><strong>Conclusions: </strong>The Pitt bacteremia score at the onset of C. auris BSI may be a useful tool in identifying patients at risk for mortality. Targeted infection prevention practices in patients receiving hemodialysis may be useful to limit poor outcomes.</p>\",\"PeriodicalId\":10463,\"journal\":{\"name\":\"Clinical Infectious Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":8.2000,\"publicationDate\":\"2024-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/cid/ciae411\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cid/ciae411","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:由于定植率和侵袭性感染报告的增加,C. auris已成为全球日益关注的问题。目前,与阿氏杆菌血流感染(BSI)患者不良预后相关的临床因素的数据还很有限:我们从美国医疗机构的两个地理区域收集了C. auris BSI患者的多中心回顾性队列。我们收集了人口统计学、临床和微生物学特征方面的数据来描述队列,并构建了多变量逻辑回归模型来了解两种临床结果的风险因素,即入院期间的全因死亡率和血培养清除率:我们的队列由187名阿氏杆菌BSI患者组成(56.1%为男性,55.6%年龄大于65岁);54.6%的患者在出院时死亡,66.9%的患者(142名有数据的患者)血培养清除。感染发生时的匹特菌血症评分与死亡率有关(几率[95% 置信区间]:每增加 1 分,几率为 1.19 [1.01,1.40] )。血液透析与微生物清除率降低(0.15 [0.05,0.43])和死亡率降低(3.08 [1.27,7.50])有关:结论:阿氏杆菌 BSI 发病时的皮特菌血症评分可能是识别有死亡风险的患者的有用工具。对接受血液透析的患者采取有针对性的感染预防措施可能有助于减少不良后果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Factors Associated with Poor Clinical and Microbiologic Outcomes in C. auris Bloodstream Infection: A Multicenter Retrospective Cohort Study.

Background: C. auris has become a growing concern worldwide due to increases in incidence of colonization and reports of invasive infections. There are limited data on clinical factors associated with poor outcomes in patients with C. auris bloodstream infection (BSI).

Methods: We assembled a multicenter retrospective cohort of patients with C. auris BSI from two geographics areas in US healthcare settings. We collected data on demographic, clinical, and microbiologic characteristics to describe the cohort and constructed multivariate logistic regression models to understand risk factors for two clinical outcomes, all-cause mortality during facility admission, and blood culture clearance.

Results: Our cohort consisted of 187 patients with C. auris BSI (56.1% male, 55.6% age >65 years); 54.6% died by facility discharge and 66.9% (of 142 with available data) experienced blood culture clearance. Pitt bacteremia score at infection onset was associated with mortality (odds-ratio [95% confidence interval]: 1.19 [1.01,1.40] per 1-point increase). Hemodialysis was associated with a reduced odds of microbiologic clearance (0.15 [0.05,0.43]) and with mortality (3.08 [1.27,7.50]).

Conclusions: The Pitt bacteremia score at the onset of C. auris BSI may be a useful tool in identifying patients at risk for mortality. Targeted infection prevention practices in patients receiving hemodialysis may be useful to limit poor outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical Infectious Diseases
Clinical Infectious Diseases 医学-传染病学
CiteScore
25.00
自引率
2.50%
发文量
900
审稿时长
3 months
期刊介绍: Clinical Infectious Diseases (CID) is dedicated to publishing original research, reviews, guidelines, and perspectives with the potential to reshape clinical practice, providing clinicians with valuable insights for patient care. CID comprehensively addresses the clinical presentation, diagnosis, treatment, and prevention of a wide spectrum of infectious diseases. The journal places a high priority on the assessment of current and innovative treatments, microbiology, immunology, and policies, ensuring relevance to patient care in its commitment to advancing the field of infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信